Reduced PEDF expression has been demonstrated in a variety of cancers [22], [23], although there is high PEDF expression in malignant melanoma, ocular melanoma, hepatocellular carcinoma, Wilm’s tumor and prostate cancer [24]–[28]. Here, SERPINF1 is linked to hepatocellular carcinoma.